Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
By T. Walsh, S. Casadei, Kathryn Hale Coats, E. Swisher, S. Stray, J. Higgins, Kevin C. Roach, Jessica B Mandell, Ming K. Lee, S. Ciernikova and 3 more. Journal of the American Medical Association (JAMA), 2006
757 citations recorded by the source corpus.
Subfields: Cancer Research, Genetics, Oncology
View Paper: https://www.semanticscholar.org/paper/1672de8cf50ec8228988d1fc077d6e645b69d68a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
Citations in the corpus
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing (2011, methodology): “Exonic deletions and duplications were validated by determining genomic breakpoints with Sanger sequencing, as previously described (33).”